X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

CRIS

Closed

Curis Inc

2.15
-0.17 (-7.33%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.32
Day's Range: 2.09 - 2.4821
Send
When Written:
 
0.596
Curis Inc. is a biotechnology company that develops and commercializes innovative drug candidates for the treatment of cancer. The company's lead product candidate is called CA-4948, which is a small molecule inhibitor of the protein IRAK4. This protein plays a critical role in the activation of the immune system and the development of cancer.

Curis was founded in 2000 and is headquartered in Lexington, Massachusetts. The company has a team of experienced scientists and researchers who work on the discovery and development of new drugs. Curis also has partnerships with other companies and research institutions to advance its drug candidates.

In addition to CA-4948, Curis has several other drug candidates in development, including CA-327, which is a small molecule inhibitor of the protein CK1α, and CA-170, which is a small molecule inhibitor of the immune checkpoint proteins PD-L1 and VISTA. The company's goal is to develop novel therapies that can improve the lives of cancer patients.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X